Please login to the form below

Not currently logged in
Email:
Password:

APCO Worldwide appoints chair of UK health practice

James Tyrrell joins London branch of global comms group

APCO Worldwide James TyrrellGlobal communications agency APCO Worldwide has appointed James Tyrrell as director and chair of its UK health practice.

Tyrell joins the London office from Insight Consulting Group, where he mostly recently served as deputy managing director having co-founded the firm in 2006.

James Ascheson-Gray, managing director of APCO's London branch, said: “We're delighted to welcome James to APCO.

“His nearly 15 years of experience as a leading healthcare consultant, and proven track record of effecting policy change in the industry, will be of great value to our clients as they face an increasingly complex and regulated environment.”

Prior to founding ICG, Tyrell served as vice chairman at the Chartered Institute of Public Relations (CIPR). He also brings experience from his time as public affairs manager and director of the London retail consortium for British Retail Consortium, and account manager at Westminster Strategy.

Tyrrell said: “Healthcare policy around the globe is evolving at a dramatic pace. Organisations wanting to be at the forefront of this evolution need the very best advice.

“APCO's global healthcare practice sets it apart in the marketplace and I'm eager to use my expertise to assist the firm's impressive client base.” 

9th September 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios - Medical Animation

MadMicrobe is an award-winning team of certified medical illustrators creating animations that engage your audience with immersive experiences that bring...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...